# Phase 2 Execution Status

**Date:** January 13, 2026  
**Status:** üîÑ **IN PROGRESS** - Data extraction scripts created, API access issues encountered

---

## ‚úÖ COMPLETED

### 1. Paired Sample Identification
- **Script:** `scripts/serial_sae/download_cbioportal_paired.py`
- **Result:** ‚úÖ **40 paired patients identified** from MSK-SPECTRUM study
- **Output:** `data/serial_sae/cbioportal_paired/paired_patients.json`
- **Note:** TCGA study has 0 paired samples (primary-only), as expected

### 2. Molecular Data Download Scripts
- **Script:** `scripts/serial_sae/download_molecular_data.py`
- **Status:** Created but encountering API access issues
- **Issue:** cBioPortal API returning empty responses for mutation/expression data

### 3. SAE Computation Script
- **Script:** `scripts/serial_sae/compute_serial_sae.py`
- **Status:** Created (placeholder - needs actual data)

---

## ‚úÖ DECISION: Focus on TCGA-OV

### MSK-SPECTRUM Status
**Decision:** Leave MSK-SPECTRUM - cohort too small and lacks gene expression data

**Reasons:**
- 40 paired patients (small cohort)
- No gene expression data available
- Limited utility for SAE pathway score computation

### TCGA-OV Status
**Decision:** Proceed with TCGA-OV direct download

**Status:**
- ‚úÖ Manifest created: 434 RNA-seq files
- ‚úÖ 482 mutation files available
- ‚úÖ 1,204 clinical files available
- ‚úÖ Download script ready: `download_tcga_ov_files.sh`
- ‚è≥ Ready to download (1-2 hours)

**Advantages:**
- Large cohort (~300-400 samples)
- Full RNA-seq expression data
- Comprehensive clinical outcomes
- Public access, no approval needed

---

## üîß NEXT STEPS (Priority Order)

### Option A: Verify Sample IDs & Try Manual Download (RECOMMENDED)
**Why:** API endpoints returning 404 - web interface is reliable

**Steps:**
1. Navigate to: https://www.cbioportal.org/study/summary?id=msk_spectrum_tme_2022
2. Select 40 paired patients (or use "Select All")
3. Download mutations + expression via "Download" tab
4. Save TSV files to `data/serial_sae/cbioportal_paired/`
5. Run `process_manual_downloads.py` to extract paired data

**Timeline:** 15-30 minutes (manual download) + 5 minutes (processing)

**Instructions:** See `scripts/serial_sae/MANUAL_DOWNLOAD_INSTRUCTIONS.md`

**Note:** MCP script created (`download_molecular_data_mcp.py`) but returns 0 mutations. May need to verify sample IDs or use manual download.

### Option B: Use GSE165897 Dataset (11 Paired Samples) - Secondary
**Why:** Single-cell RNA-seq with paired samples (treatment-na√Øve vs post-NACT)

**Steps:**
1. Download from GEO: `python3 scripts/serial_sae/download_gse165897.py`
2. Process single-cell RNA-seq data
3. Aggregate to pathway scores
4. Compute serial SAE (baseline ‚Üí progression)

**Timeline:** 2-3 days (more complex processing)

**Status:** Can proceed in parallel with TCGA-OV

### Option C: Use cBioPortal R Client (Alternative)
**Why:** R client may have better API access

**Steps:**
1. Install R and `cgdsr` package
2. Use R client to fetch mutations/expression
3. Export to CSV for SAE computation

**Timeline:** 1-2 hours (if R available)

---

## üìä CURRENT DATA ASSETS

### Identified Paired Patients
- **MSK-SPECTRUM:** 40 patients with paired primary+recurrent samples
- **Sample IDs:** Available in `paired_patients.json`
- **Study:** `msk_spectrum_tme_2022`

### Data Needed
- **Mutations:** For 80 samples (40 primary + 40 recurrent)
- **Expression:** For 80 samples (if available)
- **Clinical:** Already have sample metadata

---

## üéØ RECOMMENDATION

**Immediate Action:** Try Option A (pycbioportal client)

**If Option A fails:** Proceed with Option C (GSE165897) in parallel while resolving Option A

**Fallback:** Option B (manual download) if both A and C fail

---

## üìù FILES CREATED

1. `scripts/serial_sae/download_cbioportal_paired.py` ‚úÖ
2. `scripts/serial_sae/download_molecular_data.py` ‚ö†Ô∏è (needs API fix)
3. `scripts/serial_sae/compute_serial_sae.py` ‚ö†Ô∏è (needs data)
4. `scripts/serial_sae/README.md` ‚úÖ
5. `data/serial_sae/cbioportal_paired/paired_patients.json` ‚úÖ

---

**Next Update:** After resolving API access or switching to alternative approach
